Patents by Inventor Hinrich Wilhelm Helmut Göhlmann

Hinrich Wilhelm Helmut Göhlmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BACTERIAL ATP SYNTHASE BINDING DOMAIN
    Publication number: 20120219964
    Abstract: This invention provides an isolated mutant atpE protein and departing from said mutant atpE protein the identification of an ATPase binding domain. This invention also provides related nucleic acids, vectors, host cells, pharmaceutical compositions and articles of manufacture. This invention further provides methods for determining whether a test compound interacts with an atpE protein, i.e. with the ATPase binding domain of the present invention, as well as pharmaceuticals compositions comprising said test compound, in particular as antimicrobials, more particular as antimycobacterial agent, even more particular for treating tuberculosis in a subject.
    Type: Application
    Filed: November 29, 2011
    Publication date: August 30, 2012
    Inventors: Koenraad Jozef Lodewijk Marcel Andries, Hinrich Wilhelm Helmut Göhlmann, Jean-Marc Edmond Fernand Marie Neefs, Peter Karel Maria Verhasselt, Johann Winkler, Marc Rene De Jonge, Lucien Maria Henricus Koymans
  • Bacterial ATP synthase binding domain
    Patent number: 8088891
    Abstract: This invention provides an isolated mutant atpE protein and departing from said mutant atpE protein the identification of an ATPase binding domain. This invention also provides related nucleic acids, vectors, host cells, pharmaceutical compositions and articles of manufacture. This invention further provides methods for determining whether a test compound interacts with an atpE protein, i.e. with the ATPase binding domain of the present invention, as well as pharmaceuticals compositions comprising said test compound, in particular as antimicrobials, more particular as antimycobacterial agent, even more particular for treating tuberculosis in a subject.
    Type: Grant
    Filed: September 28, 2005
    Date of Patent: January 3, 2012
    Assignee: Janssen Pharmaceutica N.V.
    Inventors: Koenraad Jozef Lodewijk Marcel Andries, Hinrich Wilhelm Helmut Göhlmann, Jean-Marc Edmond Fernand Marie Neefs, Peter Karel Maria Verhasselt, Johann Winkler, Marc René De Jonge, Lucien Maria Henricus Koymans
  • BACTERIAL ATP SYNTHASE BINDING DOMAIN
    Publication number: 20090298874
    Abstract: This invention provides an isolated mutant atpE protein and departing from said mutant atpE protein the identification of an ATPase binding domain. This invention also provides related nucleic acids, vectors, host cells, pharmaceutical compositions and articles of manufacture. This invention further provides methods for determining whether a test compound interacts with an atpE protein, i.e. with the ATPase binding domain of the present invention, as well as pharmaceuticals compositions comprising said test compound, in particular as antimicrobials, more particular as antimycobacterial agent, even more particular for treating tuberculosis in a subject.
    Type: Application
    Filed: September 28, 2005
    Publication date: December 3, 2009
    Inventors: Koenraad Jozef Lodewijk Marcel Andries, Hinrich Wilhelm Helmut Göhlmann, Jean-Marc Edmond Fernand Marie Neefs, Peter Karel Maria Verhasselt, Johann Winkler, Marc René De Jonge, Lucien Marie Henricus Koymans